Details for New Drug Application (NDA): 061769
NDA 061769 describes CEFADYL, which is a drug marketed by Apothecon and is included in four NDAs. Additional details are available on the CEFADYL profile page.
The generic ingredient in CEFADYL is cephapirin sodium. There is one drug master file entry for this compound. Additional details are available on the cephapirin sodium profile page.
The generic ingredient in CEFADYL is cephapirin sodium. There is one drug master file entry for this compound. Additional details are available on the cephapirin sodium profile page.
Summary for 061769
| Tradename: | CEFADYL |
| Applicant: | Apothecon |
| Ingredient: | cephapirin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061769
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
